Skip to main content
Liaoning Cheng Da Co.,Ltd. logo

Liaoning Cheng Da Co.,Ltd. — Investor Relations & Filings

Ticker · 600739 ISIN · CNE000000LY3 LEI · 300300ZCCWKNUJRL8D79 Shanghai Stock Exchange Financial and insurance activities
Open in API
Filings indexed 2,288 across all filing types
Latest filing 2020-07-13 Regulatory Filings
Country CN China
Listing Shanghai Stock Exchange 600739

About Liaoning Cheng Da Co.,Ltd.

https://en.chengda.com.cn/

Liaoning Cheng Da Co., Ltd. is a diversified conglomerate operating across several strategic sectors, including biopharmaceuticals, financial services, energy development, and international trade. The company is a prominent player in the biopharmaceutical field through its specialized subsidiaries, focusing on the research, development, and production of human vaccines, most notably its market-leading purified Vero cell rabies vaccine. In the energy sector, it engages in the extraction and processing of oil shale. Its financial services division involves significant investments in securities firms and insurance companies. Additionally, the company maintains a robust international trade business, dealing in commodities such as textiles and chemicals. Liaoning Cheng Da focuses on integrating industrial operations with financial capital to drive growth across its various business units.

Recent filings

Filing Released Lang Actions
辽宁省国有资产经营有限公司关于辽宁成大股份有限公司股票交易异常波动情况的问询函的回复
Regulatory Filings Classification · 95% confidence The document is a reply letter from a controlling shareholder to an inquiry about abnormal stock trading fluctuations. It discusses the absence of major corporate actions such as asset restructuring, share issuance, acquisitions, or share repurchases during the period of abnormal trading. The document is short (398 characters) and serves as a regulatory response to a stock exchange or regulatory inquiry rather than a financial report or announcement of a report. It does not contain financial statements, earnings data, or detailed management discussion. It fits best under Regulatory Filings (RNS) as a compliance-related disclosure responding to a regulatory inquiry about stock trading activity.
2020-07-13 Chinese
股票交易异常波动公告
Regulatory Filings Classification · 95% confidence The document is a public announcement regarding abnormal stock price fluctuations of the company 辽宁成大股份有限公司 over a specific period (July 10 to July 13, 2020). It includes details about the stock price deviation exceeding 20%, the company's investigation and confirmation that no undisclosed material information exists, and a risk warning to investors. The document is short (1272 characters) and serves as a regulatory disclosure about stock trading anomalies rather than a financial report or detailed analysis. It does not contain financial statements, management discussion, or audit information. This type of announcement fits the category of Regulatory Filings (RNS), which covers general regulatory announcements and compliance disclosures that do not fit other specific categories.
2020-07-13 Chinese
关于广发证券2020年6月主要财务信息的公告
Regulatory Filings Classification · 95% confidence The document is a short announcement (1018 characters) from Liaoning Chengda Co., Ltd. regarding the main financial information of its investment in GF Securities as of June 2020. It includes unaudited financial data for GF Securities and a note that the data is based on Chinese accounting standards and is non-consolidated. The document references a shareholder meeting decision from 2019 and advises investors to be cautious. There is no detailed financial report or comprehensive analysis, only a brief financial update and a disclaimer. The document is an announcement of financial information related to an investment, not a full financial report or earnings release. It fits best as a Regulatory Filing (RNS) because it is a general regulatory announcement providing financial information without constituting a full report or earnings release.
2020-07-08 Chinese
2019年年度权益分派实施公告
Notice of Dividend Amount Classification · 100% confidence The document is an announcement regarding the implementation of the 2019 annual dividend distribution by the company 辽宁成大股份有限公司. It details the dividend per share, relevant dates for dividend distribution, tax treatment for different shareholders, and contact information for inquiries. It is not a full annual report or financial statement but a specific announcement about dividend payment details following the approval at the 2019 annual general meeting. This fits the definition of a Notice of Dividend Amount (DIV) filing, which announces dividend amounts, payment dates, and details for shareholders. The document length is short (2146 characters) and focused solely on dividend distribution, confirming it is not a full report but a dividend notice.
2020-06-12 Chinese
关于广发证券2020年5月主要财务信息的公告
Regulatory Filings Classification · 95% confidence The document is an announcement by Liaoning Chengda Co., Ltd. regarding the main financial information of GF Securities for May 2020. It includes unaudited, non-consolidated financial data such as revenue, net profit, and net assets for the month and year-to-date periods. The document states it is a disclosure of financial information of an investee company, not a full financial report of Liaoning Chengda itself. The length is short (972 characters), and it is a financial update announcement rather than a full report. It does not contain comprehensive financial statements or detailed analysis typical of Annual Reports (10-K) or Interim Reports (IR). It is also not a certification or regulatory filing. Therefore, it fits best as a Regulatory Filing (RNS) because it is a general regulatory announcement disclosing financial information of a related company without constituting a full financial report.
2020-06-04 Chinese
2020年第二次临时股东大会的法律意见书
Regulatory Filings Classification · 95% confidence The document is a legal opinion letter from a law firm regarding the legality of the convening and procedures of a company's 2020 second extraordinary general meeting of shareholders. It details the review of meeting notices, attendance, voting procedures, and results, concluding the meeting was legally valid. It does not contain financial statements or results, nor is it a report of financial performance or management discussion. It is not an announcement of voting results but a legal opinion on the meeting's legality. Therefore, it fits best under Regulatory Filings (RNS) as a legal compliance document related to corporate governance and shareholder meetings, but not a direct governance report or voting result announcement.
2020-05-25 Chinese

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.